JOHNSON & JOHNSON (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Address

ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933

Founded

1887

Number of Employees

131,900

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)
$7,315,945 $5,110,921 $9,002,039 $6,378,536 $6,051,930 $6,596,068 $3,194,096 $3,457,727 $6,037,093 $5,054,474 $1,610,648 $5,437,225
Average Price $102.35 $100.63 $112.94 $128.42 $138.38 $135.55 $148.05 $165.03 $170.61 $162.60 $157.20 $129.10
# Shares Purchased 71,480,144 50,786,855 79,703,443 49,668,435 43,733,787 48,663,158 21,574,345 20,952,063 35,385,865 31,085,414 10,245,960 42,116,315
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date 61.2% 64.0% 46.1% 28.5% 19.2% 21.7% 11.4% 0.0% -3.3% 1.5% 5.0% 27.8%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 94.0%
Excess Total Return -120.6% -109.0% -122.5% -101.2% -85.6% -71.4% -63.4% -31.7% -40.6% -29.9% -2.4% -66.2%
Quartile Rank
Percentile Rank 50% 51% 46% 47% 45% 48% 35% 45% 42% 39% 52% 60%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)